Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$10.66 USD
-0.02 (-0.19%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $10.66 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $0.07 | -18.18% |
Earnings Summary
For their last quarter, Amicus Therapeutics (FOLD) reported earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.03 per share. This reflects a positive earnings surprise of 100.00%. Look out for FOLD's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of $0.07 per share, reflecting a year-over-year increase of 200%.
Earnings History
Price & Consensus
Zacks News for FOLD
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
FOLD: What are Zacks experts saying now?
Zacks Private Portfolio Services